News | Breast Imaging | October 09, 2026

The Mercy Medical Center’s Tyanna O’Brien Center for Women’s Imaging has been recognized as a Comprehensive Breast Imaging Center by the ACR.

Maryland Hospital Earns Comprehensive Breast Imaging Center Accreditation from ACR

Oct. 6, 2026 — The American College of Radiology (ACR) has recognized Mercy Medical Center’s Tyanna O’Brien Center for Women’s Imaging as a Comprehensive Breast Imaging Center (CBIC), a designation that recognizes breast imaging facilities that achieve excellence through participation in the ACR’s rigorous breast-imaging accreditation programs.

The ACR awards the CBIC designation to centers that are fully accredited in mammography, stereotactic breast biopsy, breast ultrasound, including the ultrasound-guided breast biopsy module, and breast MRI. The designation recognizes a center’s commitment to quality assurance and improving women’s health through comprehensive breast imaging services.

The Center for Women’s Imaging at Mercy is a dedicated breast imaging and diagnostic center located at The Weinberg Center at Mercy in downtown Baltimore. The Center’s radiologists specialize in the diagnosis, screening and prevention of breast cancer and breast disease. Services include screening and diagnostic 3D mammography, breast ultrasound, breast MRI, breast biopsies and imaging-guided localization procedures.

Breast Imaging Accreditation

The CBIC designation is based on the ACR’s comprehensive accreditation requirements for breast imaging. According to the ACR, the designation provides recognition of a facility’s commitment to quality and includes a comprehensive assessment of the medical imaging facility, an ongoing process for self-assessment and recognition among patients, providers, payers and administrators.

“We are extremely proud that the Tyanna O’Brien Center for Women’s Imaging at Mercy has earned this important recognition from the American College of Radiology,” said Deepa Masrani, M.D., Director, Center for Women’s Imaging at Mercy. “This designation reflects the commitment of our entire breast imaging team to providing high-quality imaging and diagnostic services for the women we serve.”

The Tyanna O’Brien Center for Women’s Imaging is part of Mercy’s broader commitment to comprehensive breast care. Mercy introduced advanced Genius™ 3D Mammography™ exams featuring 3DQuorum technology in 2024. The technology provides three-dimensional breast imaging designed to address the effects of overlapping breast tissue that can make abnormalities more difficult to detect on conventional mammography.

Since earlier this year, Mercy has been offering Contrast Enhanced Digital Mammograms, a highly effective diagnostic tool in the early detection of breast cancer.

Facilities that achieve and maintain the ACR’s Comprehensive Breast Imaging Center designation are invited to participate in the ACR National Mammography Database (NMD).

Participation allows centers to benchmark practice performance, compare processes and outcomes with similar practices nationwide, identify opportunities for quality improvement and receive reports every six months.

The ACR’s CBIC designation remains in effect as long as the center’s required breast imaging services maintain their ACR accreditations.

 

Breast Imaging Center

 


Additional Content

News | Women's Health

Nov. 9, 2026 — DeepLook Medical has announced promising results from a new clinical study conducted at Oxford University ...

Time November 10, 2026
arrow
News | Enterprise Imaging

Nov. 3, 2026 — AGFA HealthCare recently announced that Rush University System for Health has selected AGFA HealthCare's ...

Time November 06, 2026
arrow
News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Lung Imaging

Oct. 23, 2026 — The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute recently ...

Time October 23, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
Subscribe Now